nasdaq:gild
|
117910
|
Apr 21st, 2024 12:00AM
|
Immunomedics
|
13K
|
107.00
|
Open
|
|
Apr 20th, 2024 11:30PM
|
Apr 20th, 2024 11:30PM
|
Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers.
|
Open
|
Antibody-drug conjugates, Oncology, Biopharmaceutical, and Monoclonal antibodies
|
Open
|
300 The American Rd
|
Morris Plains
|
New Jersey
|
US
|
07950
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
5807055
|
Apr 21st, 2024 12:00AM
|
Kite Pharma
|
141K
|
4035
|
Open
|
|
Apr 20th, 2024 11:30PM
|
Apr 20th, 2024 11:30PM
|
At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit.
Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite.
Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk.
See our community guidelines: http://bit.ly/2DznMNw
|
Open
|
Cancer Treatment, Engineered Autologous Cell Therapy (eACT), Immunotherapy, T-Cells, and cell therapy
|
Open
|
2400 Broadway
|
Santa Monica
|
California
|
US
|
90404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
163993
|
Apr 21st, 2024 12:00AM
|
Gilead Sciences
|
613K
|
14483
|
Open
|
|
Apr 20th, 2024 11:30PM
|
Apr 20th, 2024 11:30PM
|
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.
Social Media Guidelines: https://www.gilead.com/social-media-guidelines
|
Open
|
|
Open
|
333 Lakeside Drive
|
Foster City
|
CA
|
US
|
94404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
163993
|
Apr 20th, 2024 12:00AM
|
Gilead Sciences
|
613K
|
14483
|
Open
|
|
Apr 19th, 2024 11:28PM
|
Apr 20th, 2024 05:03PM
|
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.
Social Media Guidelines: https://www.gilead.com/social-media-guidelines
|
Open
|
|
Open
|
333 Lakeside Drive
|
Foster City
|
CA
|
US
|
94404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
5807055
|
Apr 20th, 2024 12:00AM
|
Kite Pharma
|
141K
|
4035
|
Open
|
|
Apr 19th, 2024 11:28PM
|
Apr 20th, 2024 05:03PM
|
At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit.
Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite.
Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk.
See our community guidelines: http://bit.ly/2DznMNw
|
Open
|
Cancer Treatment, Engineered Autologous Cell Therapy (eACT), Immunotherapy, T-Cells, and cell therapy
|
Open
|
2400 Broadway
|
Santa Monica
|
California
|
US
|
90404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
117910
|
Apr 20th, 2024 12:00AM
|
Immunomedics
|
13K
|
107.00
|
Open
|
|
Apr 19th, 2024 11:28PM
|
Apr 20th, 2024 05:03PM
|
Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers.
|
Open
|
Antibody-drug conjugates, Oncology, Biopharmaceutical, and Monoclonal antibodies
|
Open
|
300 The American Rd
|
Morris Plains
|
New Jersey
|
US
|
07950
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
5807055
|
Apr 19th, 2024 12:00AM
|
Kite Pharma
|
141K
|
4042
|
Open
|
|
Apr 18th, 2024 11:35PM
|
Apr 18th, 2024 11:35PM
|
At Kite, a Gilead Company, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit.
Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite.
Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk.
See our community guidelines: http://bit.ly/2DznMNw
|
Open
|
Cancer Treatment, Engineered Autologous Cell Therapy (eACT), Immunotherapy, T-Cells, and cell therapy
|
Open
|
2400 Broadway
|
Santa Monica
|
California
|
US
|
90404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
117910
|
Apr 19th, 2024 12:00AM
|
Immunomedics
|
13K
|
107.00
|
Open
|
|
Apr 18th, 2024 11:35PM
|
Apr 18th, 2024 11:35PM
|
Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers.
|
Open
|
Antibody-drug conjugates, Oncology, Biopharmaceutical, and Monoclonal antibodies
|
Open
|
300 The American Rd
|
Morris Plains
|
New Jersey
|
US
|
07950
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
163993
|
Apr 19th, 2024 12:00AM
|
Gilead Sciences
|
613K
|
14515
|
Open
|
|
Apr 18th, 2024 11:35PM
|
Apr 18th, 2024 11:35PM
|
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.
Social Media Guidelines: https://www.gilead.com/social-media-guidelines
|
Open
|
|
Open
|
333 Lakeside Drive
|
Foster City
|
CA
|
US
|
94404
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:gild
|
117910
|
Apr 18th, 2024 12:00AM
|
Immunomedics
|
13K
|
107.00
|
Open
|
|
Apr 17th, 2024 11:43PM
|
Apr 18th, 2024 06:23PM
|
Immunomedics is a leader in next-generation antibody-drug conjugate (ADC) technology, committed to help transform the lives of people with hard-to-treat cancers.
|
Open
|
Antibody-drug conjugates, Oncology, Biopharmaceutical, and Monoclonal antibodies
|
Open
|
300 The American Rd
|
Morris Plains
|
New Jersey
|
US
|
07950
|
|
Gilead
|
Health Care
|
Pharmaceuticals & Biotechnology
|